Hemorrhagic shock (HS) management is based on a timely, rapid, definitive source control
of bleeding/s and on blood loss replacement. Stop** the hemorrhage from progressing …

This review of vasopressin in septic shock differs from previous reviews by providing more
information on the physiology and pathophysiology of vasopressin and vasopressin …

Septic shock is defined by the need for vasopressor agents to correct hypotension and lactic
acidosis resulting from infection, with 30%-40% case fatality rates. The care of patients with …

Background Vasopressin (AVP) is commonly added to norepinephrine (NE) to reverse
shock in patients with sepsis. However, there are no data to support the appropriate strategy …

A shift of approach from 'clinics trying to fit physiology'to the one of 'physiology to clinics', with
interpretation of the clinical phenomena from their physiological bases to the tip of the …

Background: Guidance for the discontinuation of vasopressors in the recovery phase of
septic shock is limited. Norepinephrine is more easily titrated; however, septic shock is a …

Background: There is little data guiding clinicians on how to discontinue vasopressors
among septic shock patients on concomitant norepinephrine (NE) and vasopressin (VP) …

Rationale: Vasopressors such as norepinephrine are first line for support of mean arterial
pressure (MAP) in the management of septic shock. Their use, however, is commonly …

Objective The impact of vasopressin and norepinephrine discontinuation order in the
recovery phase of septic shock remains controversial. This systematic review and patient …

Study Objectives Patients with septic shock often require vasoactive agents for
hemodynamic support; however, the optimal approach to discontinuing these agents once …